There is absolutely no reason for GERN to get dragged down. Yet, it has created an excellent opportunity for those seeking to add more!
The copycats will scramble to get out!! But, that gives an excellent opportunity to shorts, both who want to short and those who want to cover cheap!!! What a brainwash by the betters!! But the fools will certainly fall for the brainwash. This Brexit is the best tging that took place. Now, the British will be out of the German-French dominated union, and will get its ties closer to the USA and its Commonwealth countries - India, Canada, Australia, Hong Kong and South Africa which jointly make up potentially a larger economic block than the bloody bloody bureaucratic EU. China will be now more nervous; but, the Russians will be happy to extend its friendly hand to Britain. All in all, the Sun will rise again for the British nation. Scotland issue will evaporate. But, the WS wolves and the spicy-stories seeking media will have a filed day to-day. What a bloody world!!!
two things I like to point out here; 1. ODD was quickly granted for both MF and MDS, meaning safety or toxicity really must not had been a serious concern. 2. The same FDA granted license to Jakafi inhibitor which apparently has much more serious side effects, meaning the MF/MDS trials were extended beyond Mayo's studies simply to get adequatrely large and varied-genomic background patient base to determine optimum dosage(s). I believe, once these Janssen trials are ended, and ended quickly as explained by Cabeman abov, Imet's usage will be widely recommended and used. The issue then will be: Geron with only 17 employees and inexperienced management will not be able to handle the volumoinous demand of the drug and JNJ will have to take over the manufacturing and distribution fully from the hands of the bozos at Geron. Then, their hefty compensations will be grossly unjustified. Perehaps that is why Scarlett threw the acquisition ball to justify their presence. We will have to see if that will be allowed by instituional holders who may have been quietly, and cheaply, accumulating!!
There is yet another possibility that explains why Scarlett is loved on this board: There must be paid agents of WS hedge funds which are manipulating SP to increase their day-trading gain. These paid agents, constantly present on this board and apparently paid meager compensation for posting lies on this board, like Scarlett because uncertainty and the fake acquisition ball he threw allows the SP to fluctutate like a yo-yo while remaining low. What a corruption of our securities trading system!!!
are all traders who are looking for pennies a share a day!! They love Scarlett because he has managed the SP to be at or below $3 so that these lovers can use less of their money to make their living!! They have limited amount of money and want to make enough to live. Naturally, then, they prefer SP below $3!! If the SP reaches $5 and above the institutional traders will outwit them and they aren't smart enough to beat the institutional lions! What will these lovers do after JNJ does something to take the SP above $5? Well..... they will have to find an another stock to make their living!! And, then, they will disappear from this board!!! Until then, just tolerate them!
Mangy, thanks for posting this abstract which in a few words gives really the gist of where IMET works and what is its potential use. We, on this board, need to know only that much. Any detailed explanation is really out of place here and should belong to appropriate scientific publications. This board really is not an appropriate place to get into any more sophistication of the subject. Thanks again.
Even an infested product contains certain parts that are good!! If you are one of those, get educated from what I post! (Of course, if you are smart!)
Perhaps those who are paid agents and those who are shorts or day-traders - they all love Scarlett because Scarlett has helped them make their living!!! Of course, some brain-washed #$%$ may have fallen in line with them!!!
Larry, I haven't looked at his CHMA involvement; but, have carefully reviewed all he has done at Geron since he was hired and also what Huh has done. Based on that, I am not convinced that they did their job ethically right. Therefore, I have always wondered who these so-called Scarlett lovers on this board are, unless they all are vested interests!!! Of course, I will not be surprised to find that Huh and Scarlett are not in real good terms with each other or Huh has been subdued by Scarlett.
If any one on this board thinks that a CEO who squeezes millions in comppensation long before shareholders see a penny and that too to run a compoany with just 17 or so employees and no visible workload or product-development in hand and apparently nothing else to do, then, he/she must be a brainwashed nut who can't think in real light!!! I am amazed to see many of such people, some calling themselves, pundits!!! Do you know of any one on the Geron board who has bought even a hundred Geron shares with his/her own money in the last two years when the SP had really hit lows and had an excellent opportunity to grab those really cheap if they really thought it was a great buy?!!!!
Well, that the results should be positive can be easily judged based on the CRs and CIs obtained through the Mayo's work, it still got the FDA's compete halt!! therefore, it is a thoughtless conjecture expressed by many on this board that the magic of trial results is behind the depressed SP. I think the WS is waiting for a deeper commitment and acceptrance from JNJ for continuation of development of IMET. Once the institutions are convinced of that, they will plunge in heavily, when the scared shorts will scramble to cover, jacking up the SP to a new high. i personaaly do not beleve that the interested institutrions are that much concerned about the trial results; they apparently do not trust Geron managemet and want JNJ to continue.
that the SP will bounce much earlier than the results for the current trials are announced. This is because JNJ will not be in a hurry to do that but will be in a hurry to give their consent for the "continuation" to Geron management which will be in a hurry to announce that!! A continuation decision by JNJ very well will mean that the trial results are encouraging. Therefore, in my view, instaed of the trial results, investors should look for the continuation decision by JNJ.